In the fourth quarter, health care stocksA financial instrument giving the holder a proportion of the ownership and earnings of a company. shook off some of their politically hobbled 2019 underperformance. Despite the sector’s off year, Chief Investment Officer Jim Lowell explained why we’ll continue to overweight health care stocks in our recent quarterly webinar*: 2020 Conflicts—Impeachment, Tariffs & Global Dysfunction.
Please enjoy the excerpt below and click here for the full webinar replay to hear more.
* * * * *
Jim Lowell: Longstanding clients here at the firm know that we’ve been overweight health care, not just for a year or two, but for decades. And the reality is that the sector, which accounts for about 18% of our economy, continues to present both the necessary growth story—our aging demographic population’s demand for more and less invasive ways to treat all kinds of illnesses on a going-forward basis—as well as creating a global emerging market and emerging growth story as economies around the world begin to increase the number of consumers who are able to afford not just rudimentary but increasingly better modes of health care and pharmaceutical cures.
Jim Lowell: So we think that the health care sector for a long-term investor is effectively a no-brainer. That said, inside of any given year, especially inside of a politicized election year where drug prices are often used by both sides as a way to try to gain political favor, the market reaction can be fairly negative in the short term. I would expect that we’d see some volatilityA measure of how large the changes in an asset’s price are. The more volatile an asset, the more likely that its price will experience sharp rises and steep drops over time. The more volatile an asset is, the riskier it is to invest in. this year because it is an election year, but for long-term investors like us, if people are selling on headline fears, we’re able to buy a sector we believe in long-term at a discounted prices.
*Webinar recorded after the market closed on January 23, 2020.
Disclaimer: This material is distributed for informational purposes only. The investment ideas and opinions contained herein should not be viewed as recommendations or personal investment advice or considered an offer to buy or sell specific securities. Our statements and opinions are subject to change at any time, without notice and should be considered only as part of a diversified portfolio. Mutual funds and exchange-traded funds mentioned herein are not necessarily held in client portfolios. Data and statistics contained in this report are obtained from what we believe to be reliable sources; however, their accuracy, completeness or reliability cannot be guaranteed.
You may request a free copy of the firm’s Form ADV Part 2A, which describes, among other items, risk factors, strategies, affiliations, services offered and fees charged.
Past performance is not an indication of future returns. Tax, legal and insurance information contained herein is general in nature, is provided for informational purposes only, and should not be construed as legal or tax advice, or as advice on whether to buy or surrender any insurance products. Personalized tax advice and tax return preparation is available through a separate, written engagement agreement with Adviser Investments Tax Solutions. We do not provide legal advice, nor sell insurance products. Always consult a licensed attorney, tax professional, or licensed insurance professional regarding your specific legal or tax situation, or insurance needs.